577 studies found for:
chelation
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
Trial to Assess Chelation Therapy (TACT)
|
||||
| 2 | Completed |
Effects of Iron Loading and Iron Chelation Therapy on Innate Immunity During Human Endotoxemia
|
||||
| 3 | Active, not recruiting |
Combo Chelation Trial
|
||||
| 4 | Completed |
Combination Iron Chelation Therapy
|
||||
| 5 | Completed |
Iron-Chelating Therapy and Friedreich Ataxia
|
||||
| 6 | Completed |
Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
|
||||
| 7 | Withdrawn |
Penicillamine Chelation for Children With Lead Poisoning
|
||||
| 8 | Completed |
Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major
|
||||
| 9 | Unknown † |
Environmental Exposure to Lead and Its Health Effects on Patients With Maintenance Hemodialysis
|
||||
| 10 | Completed |
Mercury Chelation to Treat Autism
|
||||
| 11 |
Completed
Has Results |
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
|
||||
| 12 |
Completed
Has Results |
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
|
||||
| 13 |
Terminated
Has Results |
Stroke With Transfusions Changing to Hydroxyurea
|
||||
| 14 | Completed |
Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone
|
||||
| 15 | Completed |
Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
|
||||
| 16 | Completed |
Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
|
||||
| 17 | Completed |
Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
|
||||
| 18 | Completed |
Sickle Cell Disease: A Retrospective Chart Review
|
||||
| 19 | Unknown † |
Combined Chelation Treatment With Deferiprone and Deferoxamine in Thalassemia Major
|
||||
| 20 | Completed |
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
|
† Indicates status has not been verified in more than two years
